Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
Express Scripts
Julphar
Moodys
Federal Trade Commission
McKesson
UBS
McKinsey

Generated: May 20, 2018

DrugPatentWatch Database Preview

Actavis Labs Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS, and what generic and branded alternatives to ACTAVIS LABS drugs are available?

ACTAVIS LABS has one hundred and eight approved drugs.

There are three tentative approvals on ACTAVIS LABS drugs.

Summary for Actavis Labs
US Patents:0
Tradenames:83
Ingredients:74
NDAs:108

Drugs and US Patents for Actavis Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE dextromethorphan hydrobromide; guaifenesin TABLET, EXTENDED RELEASE;ORAL 091070-001 Aug 31, 2015 OTC No No ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc FENTANYL-100 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076709-004 Aug 20, 2007 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062031-002 Oct 13, 1982 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc TENUATE DOSPAN diethylpropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 012546-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Actavis Labs

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc LOXITANE IM loxapine hydrochloride INJECTABLE;INJECTION 018039-001 Approved Prior to Jan 1, 1982 3,546,226 ➤ Sign Up
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-003 Approved Prior to Jan 1, 1982 3,546,226 ➤ Sign Up
Actavis Labs Ut Inc EMLA lidocaine; prilocaine CREAM;TOPICAL 019941-001 Dec 30, 1992 4,562,060 ➤ Sign Up
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-001 Approved Prior to Jan 1, 1982 3,546,226 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ACTAVIS LABS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
QuintilesIMS
Chinese Patent Office
Fish and Richardson
Fuji
Chubb
Colorcon
Deloitte
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.